Why Did Zoetis Stock Move?

ZTSYTD-34.3%SPYYTD+5.8%XLVYTD+16.1%
Analyze ZTS →

Today’s big story: Will 2027 Be A 2022 Repeat For Stocks?

Zoetis (ZTS) stock fell 5.6% on Thursday, November 19, 2026, while the S&P 500 lost 2.0%. The same day, the company said the U.S. Department of Agriculture had licensed a new vaccine for chickens. All four of its peers fell too, and Phibro Animal Health dropped the most, by 4.2%. What did Zoetis announce, and which part of its business does the vaccine belong to?

Zoetis stock fell 5.6% in one day, while the S&P 500 lost 2.0%. If Zoetis is a big share of your savings, a fall like that cuts into money you are counting on. In a free 30-minute review, our partner advisory firm can show you ways to limit your loss if the stock falls further and to sell with a smaller tax bill. Book the free review.

Image from Pixabay

Zoetis Received A U.S. License For A Chicken Vaccine

The vaccine, Poulvac Procerta, combines three disease targets into one shot. It falls under livestock, the part of Zoetis that grew in the third quarter. Livestock sales reached $797 million in that quarter, rising 7% from a year earlier. In the U.S., management said strong poultry vaccine demand helped livestock grow 5%.

But livestock is the smaller business. Companion animal, the pet business, brought in $1.6 billion in the third quarter, and those sales fell 5%. So the new license adds to the part of Zoetis that grew, while the larger pet business shrank.

Zoetis Fell With Other Drugmakers, But Further

Zoetis is classed in the pharmaceuticals sub-industry. Of the 21 other companies there worth $2 billion or more, 20 fell on November 19. Their median drop was 2.0%, the same as the health care sector fund XLV. Only one of them fell 5% or more.

The whole market was weak. U.S. stocks slid as the selling in artificial-intelligence stocks went on, despite Anthropic’s record-breaking initial public offering. Zoetis fell alongside its group, but dropped further than the sub-industry median and further than each of its four peers.

Where Does Zoetis Stock Stand Now?

A fall this large is not new for Zoetis. Before this one, it had four drops at least this deep in the past 365 days. The latest was a 7.9% fall on November 5, the day of its third-quarter earnings call.

Over the past 12 months, the stock lost 30.1%, while the S&P 500 returned 9.7%. The shares closed at $80.79, sitting far below their 52-week closing high of $131.10 on February 27, 2026. Yet the price remains above the $69.10 low it closed at on October 1, 2026. Over the past month, Zoetis returned 2.2% while the S&P 500 lost 7.4%. The stock now trades at 3.5 times its sales of the past 12 months, against 3.1 for the S&P 500.

Zoetis is expected to report its fourth-quarter 2026 results in February 2027. That report will show how sales in companion animal, its larger business, changed from a year earlier. Management also said it is reviewing which financial measures it gives with its guidance, and plans to share an update on that call.

Zoetis has had drops like this before, and the next one may come with no warning.

Could You Hold On Through The Next Fall?

Holding on is easier when your portfolio falls less than the market. For every dollar its benchmark lost, the Trefis High Quality (HQ) Portfolio lost about 81 cents on average, holding 30 quality stocks in equal weight.

See How HQ Held Up

Spot an error or want more like this? Tell us in 10 seconds.